Quantitative measurement of whole-body glycogen metabolism and gluconeogenic flux
全身糖原代谢和糖异生通量的定量测量
基本信息
- 批准号:9761123
- 负责人:
- 金额:$ 6.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAmino AcidsBlood CirculationCarbonCitric Acid CycleConsumptionCoupledDiabetes MellitusEpidemicEtiologyExerciseFastingGluconeogenesisGlucoseGlutamineGlycerolGlycogenGlycolysisGoalsHealthInfusion proceduresIntravenous infusion proceduresIsotope LabelingIsotopesKidneyLabelLiverMagnetic ResonanceMagnetic Resonance ImagingMeasurementMeasuresMetabolicMetabolic DiseasesMetabolic PathwayMetabolismMethodologyModelingMusMuscleNon-Insulin-Dependent Diabetes MellitusObesityOrganPathway interactionsPatternPhysiologic pulsePlayPopulationProductionPublishingRoleSerumSmall IntestinesSourceTechnologyTissue MicroarrayTissuesTracerWorkblindblood glucose regulationcombatglucose productionglycogen metabolismglycogenolysisimprovedin vivomathematical modelmetabolomicsnovelpreventstable isotope
项目摘要
Project Summary/Abstract
Dysregulated endogenous glucose production is the central cause of type 2 diabetes. Recently published work
from the lab of the sponsor determined that lactate carries the highest circulatory turnover flux and is an
important TCA substrate. During these studies, a general observation made from intravenous infusion of 13C-
glucose in freely moving mice was surprisingly low labeling of glycolytic intermediates in all tissues in both fed
and fasted mice. What is the source of glycolytic intermediates if not circulating glucose? We have two
hypotheses: 1) glycolytic intermediates come from glycogen and 2) gluconeogenesis produces tissue glycolytic
intermediates. If either of these are true, these pathways are active more often and, in more tissues, than
previously thought. Here, we will utilize state of the art LC-MS metabolomics in combination with intravenous
infusion of 13C-metabolite tracers to measure these pathways in fed and fasted mice in a wide array of tissues.
LC-MS offers advantages when measuring flux through these pathways including the ability to 1) measure
labeling in glycolytic intermediates and 2) to determine quantitative labeling patterns. Utilizing this
methodology, we aim to gain a comprehensive understand of glycogen metabolism and gluconeogenesis in all
tissues. This work will not only deepen our understanding of these important metabolic pathways, but it has the
potential to uncover novel roles for these pathways in maintaining tissue and organismal health.
项目总结/摘要
内源性葡萄糖产生失调是2型糖尿病的主要原因。最近出版的作品
来自申办方实验室的研究确定,乳酸盐携带最高的循环周转通量,
重要TCA底物。在这些研究中,通过静脉输注13 C-
在自由活动的小鼠中,葡萄糖在所有组织中的糖酵解中间体的标记都令人惊讶地低,
和禁食小鼠。如果不是循环葡萄糖,糖酵解中间产物的来源是什么?我们有两
假设:1)糖酵解中间产物来自糖原,2)糖异生产生组织糖酵解
中间体的如果这两种情况中的任何一种是正确的,那么这些途径在更多的组织中比在其他组织中更频繁地活跃。
以前认为。在这里,我们将利用最先进的LC-MS代谢组学与静脉内
输注13 C-代谢物示踪剂,以测量进食和禁食小鼠在各种组织中的这些途径。
LC-MS在测量通过这些途径的通量时具有优势,包括1)测量
标记糖酵解中间体和2)确定定量标记模式。利用该
方法学,我们的目标是全面了解糖原代谢和糖原合成,
组织中这项工作不仅将加深我们对这些重要的代谢途径的理解,而且它具有
有可能揭示这些途径在维持组织和生物体健康方面的新作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tara A. TeSlaa其他文献
Lactate homeostasis is maintained through regulation of glycolysis and lipolysis
乳酸稳态通过糖酵解和脂解的调节来维持。
- DOI:
10.1016/j.cmet.2024.12.009 - 发表时间:
2025-03-04 - 期刊:
- 影响因子:30.900
- 作者:
Won Dong Lee;Daniel R. Weilandt;Lingfan Liang;Michael R. MacArthur;Natasha Jaiswal;Olivia Ong;Charlotte G. Mann;Qingwei Chu;Craig J. Hunter;Rolf-Peter Ryseck;Wenyun Lu;Anna M. Oschmann;Alexis J. Cowan;Tara A. TeSlaa;Caroline R. Bartman;Cholsoon Jang;Joseph A. Baur;Paul M. Titchenell;Joshua D. Rabinowitz - 通讯作者:
Joshua D. Rabinowitz
Tara A. TeSlaa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tara A. TeSlaa', 18)}}的其他基金
Quantitative measurement of whole-body glycogen metabolism and gluconeogenic flux
全身糖原代谢和糖异生通量的定量测量
- 批准号:
9901357 - 财政年份:2019
- 资助金额:
$ 6.12万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 6.12万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 6.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 6.12万 - 项目类别: